0 By Andrew Borgmann In BrochurePosted July 29, 2021Immunology, Infectious Disease, & Host Response READ MORE
0 By Andrew Borgmann In PublicationPosted July 5, 2021Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus READ MORE
0 By Andrew Borgmann In Tech NotePosted June 15, 2021NanoString: The key to unlocking a treasure trove of data READ MORE
0 By Andrew Borgmann In PosterPosted June 6, 2021Pharmacodynamic changes confirm the mechanism of action mediating SD-101 efficacy, in combination with pembrolizumab, in a phase 1b/2 study in metastatic melanoma (MEL-01) READ MORE
0 By Andrew Borgmann In Tech NotePosted May 15, 20214 key considerations for in vivo gene expression experiments READ MORE
0 By Andrew Borgmann In Tech NotePosted April 15, 2021In vivo preclinical efficacy studies streamlined with NanoString READ MORE
